Merck, 00020912-1VL, BBA4

Immunogen
T. brucei brucei cytoskeleton (detergent extracted)
Application
Detection of T.brucei basal bodies
Biochem/physiol Actions
BBA4 was developed by immunizing mice with extracted T. brucei brucei cytoskeleton and fusing the mouse spleen cells with the myeloma Sp2-0/Ag.
Mouse x Mouse hybridoma
Preparation Note
DMEM (D6546) + 2mM L-Glutamine (G7513) + 10% FBS / FCS (F2442)
Maintain cultures between 1-9 x 100,000 cells/ml; 5% CO₂; 37°C
Other Notes
Additional freight & handling charges may be applicable for Asia-Pacific shipments. Please check with your local Customer Service representative for more information.
This cell line is part of the European Collection of Authenticated Cell Cultures (ECACC), an international repository managed by the United Kingdom Health Security Agency (UKHSA). Genomic DNA is not available for this cell line. Use of this product by commercial organizations may require a license agreement. Commercial organizations will be contacted by [email protected] to provide further information after the order request is submitted. Any other use of this cell line is prohibited without the express written permission of UKHSA. Inquiries regarding any other authorized use of this cell line may be directed to [email protected].